Tuberculosis is the world’s leading infectious disease killer, claiming 1.5 million lives in 2018. Yet TB is preventable and curable. At the first-ever UN High-Level Meeting on TB, world leaders committed to delivering preventive TB testing and treatment to 30 million people by 2022. Only by expanding testing for latent TB infection can we finally end the global TB epidemic.
In the Gulf region, labor migration is the main source of new TB cases. Currently, those who travel to the region for work are tested for active TB with routine X-ray examinations. However, this practice does not identify asymptomatic individuals infected with latent TB, who may develop the disease and risk infecting others. Learn how Dr. Eskild Petersen, a world-renowned TB expert, is spearheading the fight to end TB in the gulf.
READ HIS STORYJoin Dr. Zellweger as he describes the updated 2019 WHO Global TB Report and ongoing progress towards ending the TB epidemic. Dr. Zellweger will also describe the latest TB testing guidelines and the use of IGRA testing as a primary screening method before treatment. Dr. Jean-Pierre Zellweger is a pulmonary physician and Medical Adviser for the Swiss Lung Association.
WATCH NOWQuantiFERON-TB Gold Plus has been added to the diagnostic catalog of the Stop TB Partnership’s Global Drug Facility (GDF), opening a new channel of support for testing and treatment in countries with a high incidence of tuberculosis (TB).
LEARN MOREAmadou Gueye has a mission. That mission is to help the many contacts of TB patients, migrants and refugees of sub-Saharan Africa access fast and accurate latent TB results, holding firm in his belief that we can better manage the disease. Amadou’s challenge is convincing decision makers and leaders in the health ministries that investing in routine tests now is ultimately cheaper than curbing a possible outbreak later.
READ HIS STORYFor Scott Halstead and his wife, Karen, their honeymoon in Africa led to a very different kind of memento being brought home. Learn more about their journey from diagnosis to treatment.
READ THEIR STORYThe CDC recommends TB blood tests (IGRAs), like QuantiFERON-TB Gold Plus, for the majority of the US testing population. QIAGEN and DIASORIN are now proud to offer LIAISON QuantiFERON-TB Gold Plus, the first and only FDA-approved, fully automated assay to aid in the diagnosis of TB infection.
LEARN MORELatent TB testing and targeted intervention reduces unnecessary treatment and supports the right of the most vulnerable to know their TB status. Choose QuantiFERON-TB Gold Plus and help prevent TB by empowering proactive, systematic testing and targeted treatment of at-risk populations.
LEARN MOREOnly by working together can we help put an end to the global TB epidemic. Learn more about latent TB and spread the word by taking our latent TB quiz and sharing your results.
Are you ready to help join the fight?
TAKE THE QUIZ